CHART-C3G/CLNP023B12011

Clinical trial NCT07331259 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07331259
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

C3 Glomerulopathy Complement-mediated Kidney Disease Proteinuria

Start date: 2026-01-01
Primary completion: 2027-03-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.